Malaysia
Search
Sign In
Change Password
Points
Sign Out
Top Medical News
Lithium appears to be no better than placebo for maintaining the acute antidepressant response to ketamine in patients with treatment-resistant unipolar depression (TRD), a recent study has shown.
Specific metabolic parameters such as waist circumference and C-reactive protein are elevated, whereas high-density lipoprotein (HDL) cholesterol levels are reduced in the presence of high levels of depression and perceived stress, a study has reported.
Preschool-aged children who are not getting enough sleep at night are at increased risk of developing attention-deficit/hyperactivity disorder (ADHD) in middle childhood, a study has found.
Men with eating disorders including anorexia nervosa (AN), atypical AN or avoidant/restrictive food intake disorder are highly likely to have low bone mineral density, a study has found.
The Short-Form Six-Dimension (SF-6D) and Health Utility Index Mark 3 (HUI3) appear to be more reliable than both the 3-level and 5-level EuroQol Five-Dimension (EQ-5D-3L and EQ-5D-5L, respectively) instrument at evaluating the quality of life (QOL) in Asians with mental health problems, according to a recent Singapore study.
Sleep difficulties are exacerbated in long-term survivors of childhood cancers, which may lead to persistent emotional distress, a new study has found.
Neither multinutrient supplementation nor food-related behavioural activation therapy appear to protect against major depressive disorder (MDD) episodes in overweight or obese adults with subsyndromal depressive symptoms, according to a recent study.
Special Reports
Globally, one in four people will be affected by psychiatric or neurological disorders during their lifetime.1 With an estimated affected population of 450 million people, mental disorders are among the leading causes of ill-health and disability worldwide.1 At the recent Lundbeck Neuroscience Symposium held at Hilton Kota Kinabalu from 3–5 November 2017, three renowned key opinion leaders from the field of psychiatry shared their insights into the optimal management of bipolar disorder and schizophrenia.
At a recent Lundbeck Neuroscience Symposium at Hilton Kota Kinabalu, Professor Bernhard Baune discussed important clinical considerations in the management of behavioural and psychological symptoms of dementia (BPSD), focussing on the role of memantine hydrochloride (Ebixa®; Lundbeck).
In this issue of MIMS PsychiatrySupplement, we bring you clinical updates related to managing depression and optimizing functional recovery in patients with depression, as well as a symposium highlight of the Lundbeck Malaysia Neuroscience Symposium.
On 6 November 2016, in conjunction with the first year anniversary of vortioxetine (Brintellix®, Lundbeck) in Malaysia, two distinguished speakers, Professor Gin S Malhi and Dr Pranab Kalita shared updates on depression and the use of vortioxetine in order to help patients with major depressive disorders (MDD) to return to their premorbid functional states. The session was followed by three case presentations.
This article presents the excerpts from the Inaugural Meeting of the Dementia Advisory Board Malaysia held on 23 January 2016 in Kuala Lumpur, highlighting the clinical evidence of Ginkgo biloba extract EGb761® in dementia, treatment recommendations from international guidelines and consensus reached during the meeting on the role of EGb761® in managing dementia.
Elderly patients on androgen deprivation therapy (ADT) as part of prostate cancer treatment may be at an increased risk of depression, a recent study states.
Conference Reports
Multidomain intervention which includes nutrition, exercise, cognitive training and vascular risk monitoring is effective in preventing dementia, findings from the FINGER study have shown.
_1_2_Square.jpg)
Use of a ginkgo biloba extract on top of standard preventive treatment is shown to improve cognitive function and overall condition after acute ischaemic stroke.
Young people who have undergone liver transplant (LT), or have autoimmune liver disease (AILD), or other chronic liver diseases have higher rates of depression and anxiety than the general adolescent population, according to a study presented at the 49th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 2016 held in Athens, Greece.
